___

• Dina C. New insights into the genetics of body weight. Curr Opin Clin Nutr Metab
• Care 2008;11:378-384.
• Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance and cardiovascular
• disease. Recent Prog Horm Res 2004;59:207-223.
• Shamseddeen H, Getty JZ, Hamdallah IN, Ali MR. Epidemiology and economic
• impact of obesity and type 2 diabetes. Surg Clin North Am 2001;91:1163-1172
• Türkiye Beslenme ve Sağlık Araştırması 2010. http://ekutuphane.sagem.gov.tr/kitaplar
• Jacobi D, Stanya KJ, Lee CH. Adipose tissue signaling by nuclear receptors in
• metabolic complications of obesity. Adipocyte 2012;1(1):4-12
• Nadir I, Oğuz D. Adipokinler. Güncel Gastroenteroloji Dergisi. 2009; 13; 107-109.
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional
• cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
• Mehta S, Farmer JA. Obesity and inflamation: A new look at an old problem. Curr
• Atheroscler Rep 2007;9:134-138.
• Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of
• adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and
• subcutaneous adipose tissues of obese humans. Endocrinology 2004;14:52273-52282.
• Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB
• protein: evidence for a peripheral signal linking adiposity and central neural networks.
• Science 1995;269:546-549.
• Chen G, Koyama K, Yuan X, Lee Y, Zhou YT, O'Doherty R, Newgard CB, Unger
• RH. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin
• gene therapy. Proc Natl Acad Sci USA. 1996 10;93(25):14795-14799.
• Orci L, Cook WS, Ravazzola M, Wang MY, Park BH, Montesano R, Unger RH.
• Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad
• Sci USA. 2004 17;101(7):2058-2063.
• Vazquez-Vela MEF, Torres N, Tovar AR. White adipose tissue as endocrine organ
• and its role in obesity. Arch Med Res 2008;39:715-728.
• Coppari R, Bjorbaek C. Leptin revisited: its mechanisms of action and potential for
• treating diabetes. Nat Rev Drug Discov 2012;11:692-708
• Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley
• GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory
• immune responses. FASEB J 1998;12:57-65.
• Konstantidines S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet
• aggregation and arterial thrombosis suggests a mechanism of atherothrombotic disease
• in obesity. J Clin Invest 2001;108:1533-1540.
• Scherer PE, Williams S, Flogiano M, Baldini G, Lodish HF. A novel serum protein
• similar to C1q, produced exclusively by adipocytes. J Biol Chem 1995;270:26746–
• -
• Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, et al.
• Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating
• AMP-activated protein kinase. Nat Med 2002;8:1288-1295.
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev
• ;26:439-451.
• Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocytederived
• plasma protein, adiponectin, suppresses lipid accumulation in class A
• scavenger receptors expression in human monocyte-derived macrophages. Circulation
• ;103:1057-1063.
• Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W. Novel interactions
• of adiponectin with the endocrine system and inflammatory parameters. J Clin
• Endocrinol Metab 2003;88:2714-2718.
• Turer AT, Khera A, Ayers CR, Turer CB, Grundy SM, Vega GL, Scherer PE. Adipose
• tissue mass and location affect circulating adiponectin levels. Diabetologia
• ;54:2515-2524.
• Juan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor
• levels. A possible link between insulin resistance and atherothrombosis.
• Diabetologia 1991;34:457-462.
• Appel SJ, Harrell JS, Davenport ML. Central obesity, the metabolic syndrome and
• plasminogen activator inhibitor-1 in young adults. J Am Acad Nurse Pract
• ;17:535-541.
• Siklova-Vitkova M, Klimcakova E, Polak J, Kovacova Z, Tencerova M, Rossmeislova
• L, et al. Adipose tissue secretion and expression of adipocyte-produced and
• stromavascular fraction-produced adipokine vary during multiple phases of weightreducing
• dietary intervention in obese women. J Clin Endocrinol Metab
• ;97:1176-1181.
• Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL,
• McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB. Prevention of obesity and
• insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes.
• ;53(2):336-346.
• Gurlek A, Bayraktar M, Kirazli S: Increased plasminogen activator inhibitor-1 activity
• in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
• Diabetes Care. 2000;23(1):88-92.
• Festa A, D’Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase
• proteins and plasminogen activator inhibitor-1 predict the development of type 2
• diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:1131-1137.
• Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-
• Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose
• angiotensinogen is involved in adipose tissue growth and blood pressure regulation.
• FASEB J 2001;15:2727-2729.
• Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen
• concentration and variants of the angiotensinogen gene in white and black children. J
• Clin Invest. 1995;95(3):948-953.
• Forrester T, McFarlane-Anderson N, Bennet F, Wilks R, Puras A, Cooper R, Rotimi
• C, Durazo R, Tewksbury D, Morrison L. Angiotensinogen and blood pressure among
• blacks: findings from a community survey in Jamaica. J Hypertens. 1996;14(3):315-
• 32. Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A, and
• Cassis LA. Adipocyte-specific deficiency of angiotensinogen decreases plasma
• angiotensinogen concentration and systolic blood pressure inmice. Am J Physiol
• Regul Integr Comp Physiol 2012;302:R244-R251.
• Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia
• induced production of acute phase reactants in adipose tissue. J Biol Chem
• ;276:42077-42083.
• Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, Coussieu
• C, Gauthier E, Courtine M, Zucker JD, et al. Serum amyloid A: production by human
• white adipocytes and regulation by obesity and nutrition. Diabetologia 2005;48:519-
• -
• Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, et
• al. Serum amyloid A as a predictor of coronary heart disease and cardiovascular
• outcome in women: the National Heart, Lung, and Blood Institute Sponsored
• Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:726-732.
• Ogasawara K, Mashiba S, Wada Y, et al. A serum amyloid A and LDL complex as a
• new prognostic marker in stable coronary artery disease. Atherosclerosis
• ;174:349–56.
• King VL, Thompson J, Tannock LR. Serum amyloid A in atherosclerosis. Curr Opin
• Lipidol 2011;22:302-307.
• Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes.
• Nature 2001;409:307-312.
• Verma S, Li SH,Wang CH, et al. Resistin promotes endothelial cell activation: further
• evidence of adipokine–endothelial interaction. Circulation 2003;108:736-740.
• Kusminski CM, Meternan PG, Kumar S. Role of resistin in obesity, insülin resistance
• and Type II diabetes. Clinical Science 2005;109:243-256.
• Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a
• lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res
• ;58:2359-2365.
• Sanders PM, Tisdale MJ. Effect of zinc-α2-glycoprotein (ZAG) on expression of
• uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett 2004;212:71-
• -
• Gong FY, Zhang SJ, Deng JY, et al. Zinc-alpha2-glycoprotein is involved in
• regulation of body weight through inhibition of lipogenic enzymes in adipose tissue.
• Int J Obes 2009;33:1023-1030.
• Yeung DCY, Lam KSL, Wang Y, Tso AW, Xu A. Serum zinc-α2-glycoprotein
• correlates with adiposity, triglycerides, and the key components of the metabolic
• syndrome in Chinese subjects. J Clin Endocrinol Metab 2009;94:2531-2536.
• Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently
• improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res
• ;65:73-82.
• Wei L, Hou X, Tatemoto K. Regulation of apelin mRNA expression by insülin and
• glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 2005;132:27-32.
• Yu S, Zhang Y, Li MZ, et al. Chemerin and apelin are positively correlated with
• inflammation in obese type 2 diabetes patients. Chin Med J 2012;125:3440-3444.
• Kloting N, Graham TE, Berndt J, et al. Serum retinol-binding protein is more highly
• expressed in visceral than in subcutaneous adipose tissue and is a marker of intraabdominal
• obesity fat mass. Cell Metab 2007;6:79-87.
• Graham TE, Yang Q, Bluher M, et al. Retinol binding protein 4 contributes to insülin
• resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
• Hammarstedt A, Graham TE, Kahn BB. Adipose tissue dysregulation and reduced
• insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells.
• Diabetol Metab Syndr 2012 19;4(1):42. doi: 10.1186/1758-5996-4-42.
• Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease
• inhibitor: a unique insulin-sensititizing adipocytokine in obesity. Proc Natl Acad Sci
• USA 2005;102:10610-10615.
• Chang HM, Lee HJ, Park HS, et al. Effects of weight reduction on serum vaspin
• concentrations in obese subjects: modifications by insulin resistance. Obesity
• ;18:2105-2110.
• Kloting N, Kovacs P, Kern M, et al. Central vaspin administration acutely reduces
• food intake and has sustained blood glucose-lowering effects. Diabetologia
• ;54:1819-1823.
• Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral
• fat that mimics the effects of insulin. Science 2005;307:426-430.
• Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ. Visfatin in overweight/obesity type
• diabetes mellitus insulin resistance, metabolic syndrome and cardiovascular
• diseases: a meta-analysis and systematic review. Diabetes Metab Res Rev
• ;27:515-527.
• Kim SR, Bae YH, Bae SK, et al. Visfatin enhances ICAM-1 and VCAM-1 expression
• through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys
• Acta 2008;1783:886-895.
• Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific
• adipokine in human adipose tissue: possible role in modulating insulin action. Am J
• Physiol Endocrinol Metab 2006;290:E1253-1261.
• Zhong X, Li X, Liu F, Tan H, Shang D. Omentin inhibits TNF-α-induced expression
• of adhesion molecules in endothelial cells via ERK/NF-kB pathway. Biochem
• Biophys Res Commun 2012;425:406-410.
• Zhong X, Zhang HY, Tan H, et al. Association of serum omentin-1 levels with
• coronary artery disease. Acta Pharmacol Sin 2011;32:873878.
• Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigenpresenting
• cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp
• Med 2003;198:977-985.
• Goralski KB,McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that
• regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007;282:28175-
• 62. Takahashi M, Takahashi Y, Takahashi FN, et al. Chemerin enhances insulin signaling
• and potentiates insulin-stimulated glucose uptake in 3T3-L1adypocytes. FEBS Lett
• ;582:573-578.
• Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor
• inducing insulin resistance in primary human skeletal muscle cells. Diabetes
• ;58:2731-2740.
• Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a
• growth hormone-releasing acylated peptide from stomach. Nature. 1999 Dec 9; 402
• (6762): 656-60.
• Aydoğan A, Akküçük S, Özkan OV, Aydın M, Motor S, Uğur M, Oruç C, Yönden Z.
• The Protective Effects Of Peptide YY And Ghrelin In Acute Biliary Pancreatitis. Acta
• Medica Mediterranea, 2014, 30(2): 323-327
• Der Lely A.J, Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the
• neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab
• ;89: 3062-3065.
• Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived
• factor with potent neuronal differentiative activity. Experimental eye research.
• ;53(3):411-4.
• Yüksel R. Homozigot Hbss Erişkin Orak Hücre Anemili Hastalarda Serum PEDF
• Düzeyleri ile hsCRP Arasındaki ilişkinin incelenmesi. Uzmanlık Tezi, Hatay: Mustafa
• Kemal Üniversitesi Tayfur Ata Sökmen Tıp Fakültesi, Tıbbi Biyokimya AD, 2014
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW.
• Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest
• ;112:1796-1808.
• Lumeng C, Bodzin J, Saltiel A. Obesity induces phenotypic switch in adipose tissue
• macrophage polarization. J Clin Invest 2007;117:175-184.
• Lorenzo M, Fernandez-Veledo S, Vila-Bedmar R, et al. Insulin resistance induced by
• tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci
• ;86:E94-104.
• Romanatto T, Roman EA, Arruda AP, et al. Deletion of the tumor necrosis factor-α
• receptor 1 (TNFR1) protects against diet-induced obesity by means of increased
• thermogenesis. J Biol Chem 2009;284:36213-36222.
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis
• factor-alpha: direct role in obesity linked-insulin resistance. Science 1993;259:87-91.
• Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissuederived
• cytokines: in vivo and in vitro investigations in humans. Am J Physiol
• Endocrinol Metab 2003;285:E257-533.